Clinical Trial Update: A Phase I Trial of Tamoxifen and 9-Cis-Retinoic Acid in Breast Cancer Patients [Phase 1]

View source ↗

Summary

Phase I clinical trial evaluating the combination of Tamoxifen and 9-cis-retinoic acid in breast cancer patients has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• 9-cis-retinoic acid (9-cis-retinoic acid)
• Tamoxifen (tamoxifen)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Breast Cancer, Breast Neoplasm | Phase 1 | Status: COMPLETED